Comparative analysis of three different panels for CpG island methylator phenotype in colorectal cancer

被引：0
|
作者：
Kim, J. H.
Cho, N. Y.
Park, S. Y.
Lee, S.
Kong, G. H.
机构：
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Inst Canc Res, Seoul, South Korea
[3] Kyung Hee Univ, Coll Med, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
564
引用
收藏
页码：124A / 124A
页数：1
相关论文
共 50 条
  • [41] CpG island methylator phenotype and patients with multiple colorectal cancers.
    Grady, WM
    Markowitz, S
    Willis, J
    GASTROENTEROLOGY, 2000, 118 (04) : A46 - A46
  • [42] Prognostic value of CpG island methylator phenotype in gastric cancer
    Xiao, Huashi
    Fu, Jiaxin
    Abe, Masanobu
    Ji, Jiafu
    Zong, Liang
    CANCER SCIENCE, 2018, 109 (08): : 2623 - 2625
  • [43] Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer
    Advani, Shailesh M.
    Swartz, Michael D.
    Loree, Jonathan
    Davis, Jennifer S.
    Sarsashek, Amir Mehvarz
    Lam, Michael
    Lee, Michael Sangmin
    Bressler, Jan
    Lopez, David S.
    Daniel, Carrie R.
    Morris, Van
    Shureqi, Imad
    Kee, Bryan
    Dasari, Arvind
    Vilar, Eduardo
    Overman, Michael
    Hamilton, Stanley
    Maru, Dipen
    Braithwaite, Dejana
    Kopetz, Scott
    CLINICAL COLORECTAL CANCER, 2021, 20 (02) : 137 - +
  • [44] CpG island methylator phenotype (CIMP) in cancer: Causes and implications
    Teodoridis, Jens M.
    Hardie, Catriona
    Brown, Robert
    CANCER LETTERS, 2008, 268 (02) : 177 - 186
  • [45] Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer
    Meessen, Sabine
    Currey, Nicola
    Jahan, Zeenat
    Parker, Hannah W.
    Jenkins, Mark A.
    Buchanan, Daniel D.
    Hopper, John L.
    Segelov, Eva
    Dahlstrom, Jane E.
    Kohonen-Corish, Maija R. J.
    CANCERS, 2021, 13 (14)
  • [46] Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype
    K Kawakami
    A Ooyama
    A Ruszkiewicz
    M Jin
    G Watanabe
    J Moore
    T Oka
    B Iacopetta
    T Minamoto
    British Journal of Cancer, 2008, 98 : 1555 - 1561
  • [47] CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer
    Cheng, Yu-Wei
    Pincas, Hanna
    Bacolod, Manny D.
    Schemmann, Gunter
    Giardina, Sarah F.
    Huang, Jianmin
    Barral, Sandra
    Idrees, Kamran
    Khan, Sajid A.
    Zeng, Zhaoshi
    Rosenberg, Shoshana
    Notterman, Daniel A.
    Ott, Jurg
    Paty, Philip
    Barany, Francis
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6005 - 6013
  • [48] Methylated genes as candidate markers for colorectal cancer screening linked to Cpg island methylator phenotype
    Zen, Hongzhi
    Harrington, Jonathan J.
    Shire, Abdirashid M.
    Rego, Rafaela L.
    Wang, Liang
    Campbell, Megan E.
    Oberg, Ann L.
    Ahlquist, David A.
    GASTROENTEROLOGY, 2007, 132 (04) : A313 - A313
  • [49] The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer
    Karpinski, Pawel
    Ramsey, David
    Grzebieniak, Zygmunt
    Sasiadek, Maria M.
    Blin, Nikolaus
    MOLECULAR CANCER RESEARCH, 2008, 6 (04) : 585 - 591
  • [50] No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
    Jia, Min
    Jansen, Lina
    Walter, Viola
    Tagscherer, Katrin
    Roth, Wilfried
    Herpel, Esther
    Kloor, Matthias
    Blaeker, Hendrik
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1359 - 1366
12345